Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Márlon Grégori Flores Custódio"'
Autor:
Gabriella Sgorlon, Tárcio Peixoto Roca, Ana Maisa Passos-Silva, Márlon Grégori Flores Custódio, Jackson Alves da Silva Queiroz, André Luiz Ferreira da Silva, Karolaine Santos Teixeira, Flávia Serrano Batista, Juan Miguel Villalobos Salcedo, Rita de Cassia P. Rampazzo, Felipe Gomes Naveca, Deusilene Vieira
Publikováno v:
Bioinformatics and Biology Insights, Vol 17 (2023)
The increased transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has generated variants of concern (VOCs) throughout the pandemic, responsible for waves of cases worldwide. To monitor mutations in the S gene of SARS-CoV-
Externí odkaz:
https://doaj.org/article/cfc9b7cbf3504365841f93e655fe4434
Autor:
Pablo Ivan Pereira Ramos, Márlon Grégori Flores Custódio, Guadalupe del Rosario Quispe Saji, Thiago Cardoso, Gisele Lucchetti da Silva, Graziela Braun, Willames M. B. S. Martins, Raquel Girardello, Ana Tereza Ribeiro de Vasconcelos, Elmer Fernández, Ana Cristina Gales, Marisa Fabiana Nicolás
Publikováno v:
BMC Genomics, Vol 17, Iss S8, Pp 447-462 (2016)
Abstract Background The emergence of multidrug-resistant Klebsiella pneumoniae is a major public health concern. Many K. pneumoniae infections can only be treated when resorting to last-line drugs such as polymyxin B (PB). However, resistance to this
Externí odkaz:
https://doaj.org/article/fdf1148a8b5d4b548afd387cf2f11298
Autor:
Guadalupe del Rosario Quispe Saji, Pablo Ivan Pereira Ramos, Elmer Andrés Fernández, Willames M. B. S. Martins, Graziela Braun, Raquel Girardello, Thiago Cardoso, Gisele Lucchetti da Silva, Márlon Grégori Flores Custódio, Marisa Fabiana Nicolás, Ana Tereza Ribeiro de Vasconcelos, Ana Cristina Gales
Publikováno v:
BMC Genomics, Vol 17, Iss S8, Pp 447-462 (2016)
BMC Genomics
BMC Genomics
Background The emergence of multidrug-resistant Klebsiella pneumoniae is a major public health concern. Many K. pneumoniae infections can only be treated when resorting to last-line drugs such as polymyxin B (PB). However, resistance to this antibiot